THE PROSTATE CANCER FOUNDATION and the U.S Department of Veterans Affairs will collaborate on a $50 million precision medicine initiative aimed at expanding prostate cancer clinical research among veterans and speed the development of new treatment options and cures for prostate cancer patients. The PCF-VA agreement was signed as part of Launch Pad: Pathways to...
As NCI paylines drop to 4%, cancer centers are tapping into their institutional funds to provide “bridge funding,” typically in $50,000 to $100,000 increments, to enable investigators to keep their labs open until better times return—next year God willing.
